Pulmonary fibrosis is a lung disease where the tissue which surrounds the air sacs (called alveoli) become scarred, making it difficult for oxygen to get into the bloodstream. Since there are various causes and risk factors for pulmonary fibrosis, we’ve compiled a list of some of the main causes and…
For the friends and colleagues who see me regularly, many of you know this week was particularly challenging for me. In addition to recovering physically from my latest medication dose and being sick, I also was dealing with the emotional swings of the steroid injections. My puppy…
The LOXL2 protein plays a critical role in the development of idiopathic pulmonary fibrosis (IPF) by helping promote lung tissue scarring, according to a study. LOXL2 is one of a family of proteins important to extracellular matrix (ECM), a non-cell component essential for providing structural and biochemical support to tissues and organs. LOXL2…
Life is tough for people with a chronic illness, but through the pain and the fatigue and all the other symptoms and side effects, they show an extraordinary passion for life and try to achieve as much as possible. With help from themighty.com, we’ve compiled a list of eight remarkable…
The Pulmonary Fibrosis Foundation (PFF), a trusted resource for the estimated 200,000 Americans with pulmonary fibrosis (PF), has published its new “Pulmonary Fibrosis Information Guide“ —  which gives patients, family members and healthcare providers a better understanding of PF as well as idiopathic pulmonary fibrosis (IPF). The 36-page guide, available online here and…
I have always been active and independent growing up. I like to meet new people and explore the outdoors. I enjoy learning and am committed to professional development. And I get excited and enthusiastic about new initiatives in my personal life, in my education and in my career.
Broadway stars at New York City’s Edison Ballroom helped raised a record $250,000 to support the battle against pulmonary fibrosis (PF) in the 7th annual ‘Broadway Belts for PFF!’ To help boost funding for PF research, actress and dedicated Pulmonary Fibrosis Foundation (PFF) advocate Julie Halston hosted the benefit show, which featured Grammy and Tony award winners. Halston…
Clinical trial results indicate that inhaled TD139 is an effective, safe and well-tolerated treatment for idiopathic pulmonary fibrosis (IPF), its maker, Galecto Biotech AB, has reported. The phase 1b/2a clinical trial (NCT02257177) was divided into two parts. Part 1 was a randomized, double-blind, single-center, placebo-controlled, single ascending dose phase 1…
The Pulmonary Fibrosis Foundation has announced that its seventh annual Broadway Belts for PFF event raised a staggering $250,000, an increase of 35 percent over the 2016 event. Find out more about pulmonary fibrosis with this quick guide to the disease. According to a report on broadwayworld.com,…
Synairgen released further positive data from its lysyl oxidase-like 2 enzyme (LOXL2) inhibitor program to treat idiopathic pulmonary fibrosis (IPF), being conducted in collaboration with Pharmaxis. A Phase 1 clinical trial is set to start this year, if toxicology studies are successfully completed. Synairgen and Pharmaxis entered a collaboration in August…
Get regular updates to your inbox.
